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Most cases of hair loss are based on premature induction of 
follicle regression (catagen). Deciphering the unknown reg-
ulation of catagen is therefore clinically important, but cata-
gen is also an excellent model for organ involution by rapid 
terminal differentiation and for epithelial cell death (apopto-
sis). We here report an assay for the controlled pharmaco-
logic induction and manipulation of catagen follicles. Dexa-
methasone-21-acetate (0.1%) was applied once daily to 
depilation-induced, growing follicles (anagen VI) on the 
backs of C57 BI-6 mice. Characteristic catagen-associated 
changes in skin color were photodocumented and assessed by 
T he control of hair follicle regression (catagen) is still obscure (cf. [1]). This hair cycle stage is clinically so important because most cases of hair loss seen in clini-cal practice involve premature termination of follicle growth (anagen) and induction of catagen. Classi-
caily, this is seen in alopecia areata, chemotherapy-induced alopecia, 
and "telogen effluvium," but also in androgenetic alopecia, where 
progressive shortening of the anagen phase results in the veil us 
transformation of terminal hair follicles (cf. [1- 6]). To develop 
more effective means of treating or preventing hair loss, it is there-
fore crucial to dissect the regulation of catagen. 
Previous studies have characterized the sequence of morphologic 
[1,7 -9] and pigmentary changes [10] during the anagen-catagen 
transformation of the follicle, and have called attention to the possi-
ble involvement of macrophages in this process [1,6,9,11]. Also, 
endogenous mitotic inhibitors [7,12,13] and a presumably finite 
number of mitotic cycles of hair matrix keratinocytes [14] have been 
invoked to explain anagen termination. Yet the exact mechanisms 
forcing the anagen follicle rhythmically into a process of rapid 
organ involution have remained unknown, probably due to the lack 
of convenient models for studying catagen. Only a very small per-
centage of spontaneously cycling hair follicles in normal skin is in 
catagen at any given time [1,4)' which makes it very tedious to study 
the complete, rapidly devolving anagen-catagen-telogen transition. 
Due to the short duration of catagen, even when synchronized 
spontaneous hair cycles, such as those of mice and rats, are exam-
ined, the yield of catagen follicles is usually very low, its initiation is 
less well-synchronized than that of anagen, and the exact time of 
spontaneous catagen initiation is unpredictable. 
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Abbreviation: DEX, dexamethasone-21-acetate. 
morphometric histology. Topical dexamethasone induced 
catagen-like follicles significantly earlier, more homoge-
neously, and also more extensively than vehicle. This process 
was inhibited by high intraperitoneal doses of cyclosporin A. 
In addition to its clinical relevance as a screening assay for 
catagen-blocking drugs, this simple murine model is an at-
tractive tool for dissecting the molecular, cellular, and devel-
opmental biology of catagen. Key words: glucocorticosteroids/ 
apoptosis/hair growth/alopecia .] Inllest Dermatol1 03:143 -147, 
1994 
Therefore, assays are required that allow the rapid, reproducible, 
and predictable induction of large, defined populations of viable 
catagen follicles, whose development over time can be followed. 
Ideally, such assays should also permit the investigator{s) to probe 
candidate drugs for the inhibition of catagen. Such assays are of 
general biologic interest, as they can be exploited for studying, e.g., 
rapid tissue involution by terminal differentiation and the biology 
of epithelial cell apoptosis in a physiologic context (catagell is a 
process of terminal differentiation [8], and keratinocyte apoptosis in 
the regressing hair bulb is a hallmark of catagen [15,16]). Here, we 
present such an assay, using the topically applied corticosteroid dex-
amethasone for the pharmacologic induction of massive catagen 
development in mouse anagen hair foUicles ill l! ivo. 
MATERIALS AND METHODS 
Animal Model Six- to eight-week-old female, syngeneic C 57 BL-6 
mice (15-20 g) were purchased from Charles River, Hannover, Germany. 
Mice were housed in community cages with 12-h light cycles at the UKRV 
Animal Facilities, FU Berlin, and were fed mouse chow and water ad libitun!. 
Only mice in the resting stage of the hair cycle (telogen) were used for these 
studies. In murine truncal skin, all melanocytes reside in hair follicles, and 
pigment production (melanogenesis) occurs exclusively during anagen. 
Thus, telogen C 57 BL-6 mice can be recognized reliably by the pink color of 
their back skin [7,12,13,17]. 
Anagcn VI Induction Under ketaminhydrochloride general anesthesia, 
telogen mice were induced to enter al1agen by depilation of all telogen hair 
shafts as described [12,17]. With this technique, all depilated telogen hair 
follicles immediately begin to transform into anagcn follicles with their 
associated melanogenesis [7,12,17,18]. This results in progressive skin pig-
mentation and thickening within 5 - 6 d, in the development of mature 
anagen VI follicles and a grey to black skin color within 8-9 d, and the 
appearance of new nniformly black hair shafts within 11-12 dafter anagen 
induction. Histologically, functionally, and macroscopically, depilation-in-
duced anagen VI follicles are indistinguishable from spontaneously develop-
ing anagen follicles. At the end of anagcn VI, follicle regression (catagen) 
occurs spontaneously 17 - 20 dafter anagen illductfon without visible loss of 
hair shafts, but with reconversion of the skin color from black to pink 
[8,10,19]. 
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Catagen Induction When all back skin follicles had just entered anagen 
VI (9 d post-depilation), 0.8 -1.0 ml of o. ~ % dexamethaso~e-21 -acetate 
(DEX) in propylene glycol (Sigma Chem.lcal Co., St. LOUIS, MO) was 
administered liberally with the help of a paintbrush to the back once dally 
from days 9-13 post-depilation. It was then assessed whether the character-
istic change of the anagen-associated black skin color to the grey of catagen 
and the pink of telogen skin occurred sooner or. later than In velucle-tre~ted 
control mice. In addition to photodocumentatlOn, skin color was classified 
into "black skin" (anagen VI), "grey skin" (catagen), "grey and pink skin" 
(catagen and telogen), and "pink skin" (telogen),. and the relative perc~ntage 
of these distinctly colored areas of the total depilated area of back skin was 
estimated. This simple macroscopic parameter allows reliable classification 
of the corresponding hair cycle stage in this mouse strain [8,10,17 -191· 
After extensive pilot assays not included here, 23 test mice were compared 
with 14 vehicle-control mice in three separate assays. Because all three assays 
yielded highly comparable results, data were pooled and means calculated; 
due to the magnitude of differences between test and control animals further 
statistical analysis was considered unhelpful, and only absolute date are 
shown. 
For morphometric quantitation of these visible changes, and to check 
whether drug administration had only affected follicle melanogenesis but 
not their cycling, skin sections were analyzed by morphometry (routine 
histology, Giemsa stain). Per group and time point, a minimum of 50 folli-
cles derived from 7 - 16 mice from three to four separate experiments were 
analyzed for the percentage of anagen versus catagen follicles, and for the 
relative percentage of early (I-III), middle (IV - V), and late (VI- VllI) 
catagen stages (cf. [8]). Data were pooled, and means, standard errors, and p 
values were calculated (independent Student t test). Using Student t test for 
paired data, we compared four different topographical back skin regions 
(neck, tail, flank, and central paravertebral back skin regions) for differences 
in the relative percentages of catagen versus anagen follicles in test and 
control groups. Follicle classification followed the detailed criteria of Straile 
el al [8), who have delineated the morphology of the anagen-catagen-telogen 
transition in the C 57 BL-6 mouse. 
Inhibition of DE X-Induced Catagen Studying the same macroscopic 
and microscopic parameters as above, we then assessed whether DEX-in-
duced catagen was inhibited by the concomitant intraperitoneal administra-
tion of cyclosporin A (CsA). As before, various administration schedules and 
CsA doses ~ere explored in pilot experiments, and the schedule and dose 
yielding the most reproducible results was selected: 250 mgjkg CsA in 0.5 
ml corn oil, containing 12.50/0 ethanol in the stock solution (SAND IM-
MUN, Sandoz Pharma Ltd.) or vehicle were injected intraperitoneally on 
days 7, 9, and 11 post-depilation (i.e., approximately 3 X 5 mg CsA per 
mouse); in addition, 0.1 % DEX was administered topically on days 9 -13 
post-depilation. Control animals were treated with 0.1 % DEX and 0.5 ml 
corn oil + 60)11 ethanol intraperitoneally. Excluding the pilot assays, the 
data reported here were pooled from a total of22 test (DEX + CsA) and 16 
control animals (DEX) studied in three separate experiments. 
RESULTS 
On the basis of the concept that activated macrophages, their cyto-
kines, and other constituents of the skin immune system playa role 
in catagen induction [6,9,11,20,21]' we examined in preparatory 
pilot studies whether immunosuppressive corticosteroids block 
spontaneous catagen development in anagen mice. Testing various 
potent topical glucocorticosteroids in the dose range previously 
demonstrated to suppress murine anagen development [22), we 
noted that none of the corticosteroids tested prolonged the length of 
anagen, compared with controls. Instead, the most potent ones 
tested, 0.05 - 0.1 % dexamethasone or DEX in propylene glycol, but 
not betamethasone or prednisolone, significantly shortened anagen 
as judged by comparing the hair cycle-associated skin color changes 
of test and control mice. To exploit this effect for developing an 
assay for the pharmacologic induction of catagen, the DEX dose and 
administration schedule with the strongest and most rapid anagen-
shortening effect was selected for further study in the experiments 
reported here. 
When C 57 BL-6 mice were treated once daily with 0.1 % DEX 
during the early and middle stage of depilation-induced anagen VI 
(days 9-13 post-depilation), both tests and control mice displayed 
uniformly black back skin on day 12 post-depilation, indicating that 
a\l follicles were in anagen VI. One day later, however, the skin 
color of test animals changed suddenly in a manner characteristic of 
catagen development: by day 13 post-depilation, 80% of test mice 
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Figure 1. Skin color changes indicating rapid and premature induction of 
catagen by topical dexamethasone (DEX). The graph depicts the percentage 
of test mice treated once daily with 0.1 % DEX topically from days 9 to 13 
post-depilation displaying a distinct skin color over at least 80% of their back 
skin area on days 12-16 after anagen induction by depilation. Control mice 
receiving propylene glycol topically arc not shown, because all control ani-
mals had homogeneously black skin on days 12-16 (100%) and showedfirsr 
changes in skin color from black to grey jpink between days 17 and 20 
post-depilation. Predominantly black skin represents fully melanized alla-
gen follicles, whereas grey to pink skin indicates catagen and telogcn devel-
opment. n = 23 mice test mice, 14 control mice, pooled from three separate 
assays. 
had developed grey back skin areas, and the remaining 20% exhib-
ited a skin color change indicating an even further progression in 
the hair cycle towards telogen (grey and pink interspersed). On day 
15 post-depilation, 78% of test animals displayed large, confluent 
pink skin zones, and on day 16 post-depilation the skin color of all 
test animals had changed to a homogeneous pink over most of the 
depilation-treated back, suggesting that all follicles had re-entered 
telogen (Fig 1, 2a). As the entire depilation-induced anagen phase in 
C 57 BL-6 mice of this age lasts about 16-19 d, the premature 
induction of catagen by topical DEX as early as on day 13 post-depi-
lation implies a shortening of anagen by 20-40%. 
In contrast, the back skin color of all control animals had re-
mained homogeneously black during this time (Fig 1) and was still 
black on day 16 (Fig 2a). Between days 17 and 20, control animals 
began to develop catagen-associated color changes, yet in more 
heterogeneously distributed, sharply demarcated, and smaller 
patches, which developed less rapidly than in test mice and dis-
played greater interindividual variation. Figure 2a shows the mac-
roscopic difference in skin color between test and control mice on 
day 16. No hair loss or any signs of overt drug or vehicle toxicity 
occurred in any of the groups, whereas some degree of skin thinning 
was notable in the DEX-treated groups. 
Morphometry revealed that all follicles in the skin of vehicle-
treated control animals had remained in anagen VI on days 15 and 
16 post-depilation, whereas the majority (79%) of follicles in the 
skin of DEX-treated animals had already entered catagen (Fig 3, 
upper two panels). Note that, histologically, DEX induces very large 
and relatively homogeneous populations of catagcn follicles that 
form the majority of all follicles seen on days t 5 and 16 post-depila-
tion and that follow a normal developmental course. When catagen 
follicles were classified into early (I-III), middle (IV, V), and late 
catagen (VII, VIII) [8), a rapid progression from early to late catagen 
forms within 1 day was evident (Fig 3, lower two panels). Relative to 
spontaneous catagen, where only very few catagen follicles in het-
erogeneous developmental stages are seen among a majority of ana-
gen and telogen follicles, DEX-induced catagen was remarkably 
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Figure 2. DEX-in.du~ed catagen and inhibition by CsA. a) DEX-induced 
skin color changes mdlcatmg catagen development. Shown are representa-
tive C 57 BL-6 mice on day 16 post-depilation that have received either 
vehicle (three mice on the lift side of the figure) or DEX (four mice on the 
right) on days 9 -13 post-depilation. Hair shafts have been partially shaved to 
demonstrate the homogeneously black skin color of control mice, as opposed 
to the pink-grey skin color of test mice, indicating rapid, extensive, and 
premature induction of a homogeneous catagen wave in the latter animals. b) 
Inhibition of DE X-induced catagen by CsA. Shown are representative C 57 
BL-6 mice on day 16 post-depilation after treatment with DEX + intraperi-
toneal CsA (twO mice on the lift), DEX (center, two mice), or vehicle (two 
mice on the right). 
homogeneous, which was evident not only from the high percent-
age of induced catagen follicles, but also from the lack of statistically 
significant differences in the percentage of catagen follicles found in 
different back skin regions (e.g. , comparing the neck and the tail 
region on day 16 post-depilation; p> 0.05). Spontaneous catagen, 
in contrast, usually begins in the neck region around day 18 post-de-
pilation and is seen last in the tail region of C 57 BL-6· back skin, 
which results in highly significant (p < 0.001) regional differences 
in the onset and speed of catagen development and visible heteroge-
neity in skin color changes over the back (not shown). 
Figure 4 demonstrates the induction of follicle forms that are 
morphologically indistinguishable from the full spectrum of spon-
taneously developing catagen follicles as characterized from C 57 
BL-6 mice [8]' On day 16 post-depilation, at a time when all control 
follicles are still in anagen VI (Fig 4a), abundant catagen stages 
1I- VI can easily be detected in DEX-induced catagen mouse skin 
(Fig 4b-e) . Histologically, catagen II - III follicles are first detected 
on day 13 post-depilation; 2 d after discontinuation of DEX-appli-
cation (day 15 post-depilation), almost all catagen follicles found 
represent catagen stages II - V (Fig 4b-d). On day 16 post-depila-
tion, a significant increase in the relative percentage of late catagen 

















































Figure 3. Morphometry of catagen induction by DEX and of its inhibition 
by CsA. The upper two pallets show the percentage of anagen versus catagen 
follicles detectable and classified by morphologic criteria on days 15 and 16 
post-depilation in mice treated with vehicle (Crtl) , 0.1 % topical dexametha-
sone (Dexa), or dexamethasone + intraperitoneal cyclosporin A (Dexa 
+ CsA). The lower two pallets differentiate the catagen follicles detected into 
early (I - III) , middle (IV,V), and late (VI - VIII) catagen forms. Bars, mea.ns 
± SEM calculated as indicated in Materials alld Methods. 
catagen development progresses at the normal pace described for 
spontaneous catagen development [8]. 
From the skin color of DEX-treated mice on day 16 post-depila-
tion (Fig 1, 2b), one suspects that the majority offollicles in the pink 
back skin is already in late catagen and mostly in telogen. Figure 3 
demonstrates, however, that this is not the case; most follicles are 
still in early and middle catagen. The dramatic changes in skin color 
seen between days 12 and 15 post-depilation (Fig 1) and the homo-
geneously pink skin color seen on day 16 post-depilation in DEX-
treated mice (Fig 2a,b) reflect the rapid and sharp decline of mela-
nogenesis very early during catagen development [7,10,18]. 
Because, in spontaneously cycling mice, homogeneously pink skin 
is only seen when all follicles are in telogen [7,12,17,19], this fur-
ther emphasizes the strength and homogeneity of DEX-induced . 
catagen. 
Very few DEX-treated anagen follicles showed discrete signs of 
follicle dystrophy. In some of those 17 - 20% anagen VI follicles 
that were still visible in DEX-treated skin on days 15 and 16 post-
depilation (Fig 3, upper panels), the width of the proximal hair bulb 
was slightly narrower than in vehicle-treated anagen VI follicles, 
mainly in follicles from the flank regions. A' minor degree of mela-
nin clumping and irregular distribution of melanin granules was 
found in about 1 % of DEX-induced catagen and telogen follicles , 
similar to though much less pronounced than the pigmentation 
disorder seen with cyclophosphamide-induced alopecia in mice [1 9] 
and humans [3, 23]. Cutaneous thinning ill both the epidermal and 
the dermal compartment was observed histologically in the skin of 
DEX-treated mice, but not in vehicle controls, as is to be expected 
from the prolonged administration of a very potent glucocortico-
steroid to the skin [24,25]. 
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Figure 4. Histologic appearance of DEX-induced catagen follicles. Giemsa-stained longitudinal sections through the skin of C 57 BL-6 mice treated by 
vehicle (a) , DEX (b -e), or DEX + CsA (f) on day 16 post-depilation . b) Catagen II, c) catagen Ill, d) catagen V, e) catagen VI. Control animals display 
exclusively anagen VI follicles (a) . Concomitant CsA administration to DEX-treated mice maintains anagen VI follicl es in their old hair cycle stage (f) . Bars, 
25 11m (a,f) , 50 11m (b -e). 
We have previously documented that the immunophilin ligand 
CsA [26] induces anagen [20] and is a potent inhibitor of both 
spontaneous catagen [271 and of chemotherapy-induced dystrophic 
catagen [19] in C 57 BL-6 mice . Therefore, high doses of CsA were 
administered on days 7, 9, and 11 (3 X 250 mg/kg intraperitone-
ally) in addition to topical DEX. This resulted in a significant retar-
dation of the DEX-induced color change indicative of catagen/te-
logen development. Figure 2b shows that 011 day 16 post-depilation 
DEX + CsA-treated mice (Fig 2a) displayed the same dark skin 
color as vehicle controls (Fig 2b) . 
Histologically, this corresponded to a complete abrogation of the 
catagen-inducing effects of DEX: all follicles in the back skin of 
DEX + CsA-treated mice were in anagen VI, as were all vehicle 
controls (Fig 3, I~pper and lower pa ,u ls). Morphologically, most DEX 
+ CsA-treated follicl es were indistinguishable from mature, nor-
mally pigmented anagen VI follicl es (compare Fig 4a with Fig 41). 
Additional controls showed that neither corn oil + ethanol intra-
peritoneally or topical propylene glycol alone, nor both together, 
significantly altered the duration of anagen compared with un-
treated , anagen-induced mice, as indicated by skin color changes (n 
= 10 mice per group). 
DISC USSION 
W e here present an assay for the rapid, reproducible, and predictablr 
pharmacologic induction of ca tagen follicles . This murine i/1 '';''0 
assay greatly simplifies sequential and comparative studies of viable 
catagen fo llicle populations for studies on the biochemical, cellular, 
and molecular level, improves the reproducibility of experiment , 
and gives access to previously unattainable quantities of catagen 
follicles in all the distinct stages of follicle regression. It allows 
generation of large "libraries" of catagen follicl es in defined, rela-
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tively homogeneous developmental. s.tages from syn~eneic ani~als 
of identical age. TI1lS assay can be utlilzed as a convement screenmg 
system for catagen-inhibitory drugs, as demonstrated by the signifi-
cant retardation of DEX-111duced catagen by CsA administration. 
Besides its applications for hair biology and clinical trichology, the 
assays will be ~sefu.1 in the study of iI~vo~ution by terminal differen-
tiation and eplthehal cell apoptosls II'! SItU. 
Corticosteroids have long been used for the modulation of exper-
imental hair growth in rodents [1,22,28]. Potent glucocorticoster-
oids are commonly administered to induce hair regrowth in various 
forms of alopecia, are occasionally associated with the induction of 
hypertrichosis as an undes~rable effect, and can even induc~ alopecia 
when given systemIcally 111 very hIgh doses for a long tIme [1,4) . 
Because we had shown that topical betamethasone completely 
blocks depilation-induced anagen development in mice [22), we 
expected that potent corticoster.oids might ~Iso suppress catage~l, 
particularly 111 view of the potential role of activated macrophages m 
catagen development [6,9,11,21). !hat,. surp~isingly, topical DEX 
is a potent illducer of catagen cautIOns IS aga1l1st the concept that 
macrophages are crucial factors in catagen development, because 
their activation, functIOns, and cytokme release should be inhibited 
by DEX [29]. The massiv~ catagen in~uction by DEX described 
here is in line With our prevIOus observatIOn that topical DEX forces 
cyclosphosphamide-damaged anagen follicles to abruptly enter into 
a dystrophic catagen stage (as opposed to dystropll1c anagen) [19) . 
Although our study was not designed to address the (likely 
complex) molecular mechanisms of DEX-induced catagen, one 
wo nders whether DEX-induced apoptosis of follicle keratinocytes 
plays a role, because glucocorticosteroids are potent inducers of 
thymocyte apopto~is [16,30) and .because light micros~opic signs 
suggestive ofkerat1l10cyte ~popt0515 (c~. [17]) were occaSIOnally de-
tected in DEX-treated folltcles . In addItIOn, DEX-mduced catagen 
was inhibited by CsA, a known inhibitor of thymocyte apoptosis 
[31]. On the one hand, the potency of CsA as an inhibitor of DEX-
induced catagen further attests to the potential of CsA for the treat-
ment of hair loss. On the other hand, the remarkable antagonism of 
twO generally synergistic im.munosuppressive drugs, DEX and CsA 
[29), raises the possibility that both drugs share signal transduction 
target molecule(s)jpathways (d. [32]) that are crucial to the ana-
gen-catagen transformation of the murine hair follicle. These may 
be dissected in the present model and are interesting targets for new 
classes of hair growth-modulatory drugs: catagen blockers for the 
prevention and treatment of alopecia and catagen inducers for the 
management of hirsutism and hypertrichosis. 
Molecular studies employing this model for dissecting the regu-
lation of catagen must take into account that prolonged glucocorti-
coid administration alters gene expression and cell functions of 
many cutaneous cell populations [22,24,25,29]' as suggested by the 
DEX-induced cutaneous thinning and the occasionally seen melan-
ization disorder of DEX-treated follicles. However, no significant 
differences in follicle morphology were noted between DEX-in-
duced catagen follicles and spontaneous ones. Also, DEX-induced 
catagen follicles traversed all eight substages of catagen develop-
ment outlined for spontaneous catagen development in these mice 
within the physiologic time span [8] . In addition, the sudden decline 
in melanogenic activity associated with spontaneous catagen [24] 
was also seen in our model, as evidenced by the corresponding 
change in skin color and follicle pigmentation. As in spontaneous 
catagen [10], this is associated with a highly significant decrease in 
tyrosinase and DOPAchrome tautomerase activity in the skin of 
DEX-treated mice (Paus et ai, manuscript in preparation) . In addi-
tion, the response of the DEX-induced catagen transformation of 
anagen follicles to CsA was highly comparable to that of spontane-
ous catagen [27] . T aken together, this strongly suggests physiologic 
relevance of this model. 
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